Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CLASSYS is a global leader in the medical aesthetics sector with over 38,000 devices sold in more than 70 countries. Its flagship products—such as Shurink Universe/Ultraformer MPT and Volnewmer/Everesse—are commercialized globally for non-invasive skin lifting, wrinkle reduction, and body contouring. The company has demonstrated strong growth with a compound annual sales growth rate of over 30% from 2018 to 2023. Clinical results are supported by regulatory approvals including U.S. FDA clearance for Volnewmer/Everesse and CE MDR certification pending for European expansion
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CLASSYS.